Trial intelligence / Profile preview

Metabolic Impact of Qlaira vs Triquilar in Healthy Women

NCT00185224Phase 2Completed

Sponsor
Bayer
Start
Mar 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of estradiol valerate + dienogest in contraception, sponsored by Bayer. Started Mar 2005; status: completed.

02

Drugs

estradiol valerate + dienogest
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00185224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00185224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call